Summit Trail Advisors LLC Buys 1,189 Shares of CME Group Inc. (NASDAQ:CME)

Summit Trail Advisors LLC grew its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 28.8% in the first quarter, according to its most recent filing with the SEC. The firm owned 5,323 shares of the financial services provider's stock after acquiring an additional 1,189 shares during the quarter. Summit Trail Advisors LLC's holdings in CME Group were worth $1,412,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently modified their holdings of CME. Norges Bank acquired a new stake in CME Group in the fourth quarter worth approximately $1,107,389,000. Price T Rowe Associates Inc. MD raised its stake in shares of CME Group by 89.9% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock worth $1,923,047,000 after buying an additional 3,921,278 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in shares of CME Group in the fourth quarter valued at $871,063,000. GAMMA Investing LLC lifted its holdings in shares of CME Group by 32,941.0% in the first quarter. GAMMA Investing LLC now owns 1,858,887 shares of the financial services provider's stock valued at $493,144,000 after buying an additional 1,853,261 shares during the period. Finally, Egerton Capital UK LLP bought a new position in CME Group during the fourth quarter valued at about $223,967,000. Institutional investors own 87.75% of the company's stock.

Insider Buying and Selling at CME Group

In related news, General Counsel Jonathan L. Marcus sold 390 shares of the stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $277.50, for a total value of $108,225.00. Following the transaction, the general counsel owned 6,708 shares in the company, valued at approximately $1,861,470. This represents a 5.49% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Charles P. Carey sold 500 shares of the firm's stock in a transaction that occurred on Tuesday, June 10th. The shares were sold at an average price of $265.35, for a total transaction of $132,675.00. Following the transaction, the director directly owned 4,900 shares in the company, valued at approximately $1,300,215. The trade was a 9.26% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,400 shares of company stock valued at $3,680,610 in the last quarter. Corporate insiders own 0.30% of the company's stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Keefe, Bruyette & Woods lifted their price objective on shares of CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research note on Thursday, April 24th. UBS Group increased their price objective on CME Group from $290.00 to $305.00 and gave the company a "buy" rating in a research report on Friday, April 25th. Morgan Stanley lifted their target price on CME Group from $301.00 to $304.00 and gave the stock an "overweight" rating in a report on Thursday, April 24th. JPMorgan Chase & Co. cut their target price on CME Group from $223.00 to $211.00 and set an "underweight" rating on the stock in a research report on Thursday, April 24th. Finally, Piper Sandler increased their price target on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research report on Tuesday, April 8th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating and five have given a buy rating to the stock. According to MarketBeat, CME Group presently has an average rating of "Hold" and an average price target of $258.20.

CME Group Stock Up 0.1%

Shares of CME traded up $0.40 during trading hours on Wednesday, reaching $275.82. The company's stock had a trading volume of 2,074,746 shares, compared to its average volume of 2,198,422. The company has a 50 day moving average of $275.71 and a two-hundred day moving average of $257.22. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. The firm has a market cap of $99.39 billion, a price-to-earnings ratio of 27.75, a P/E/G ratio of 3.74 and a beta of 0.44. CME Group Inc. has a 1-year low of $193.17 and a 1-year high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, beating the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.71% and a return on equity of 14.03%. The firm had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. During the same quarter in the prior year, the business earned $2.50 EPS. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th were paid a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.81%. The ex-dividend date of this dividend was Monday, June 9th. CME Group's dividend payout ratio (DPR) is presently 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.